Molecular imaging of atherosclerosis in translational medicine

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 5, 2011, Pages 969-975

  Perrone Filardi, Pasquale ^a   Dellegrottaglie, Santo ^a,b   Rudd, James H F ^c   Costanzo, Pierluigi ^a   Marciano, Caterina ^a   Vassallo, Enrico ^a   Marsico, Fabio ^a   Ruggiero, Donatella ^a   Petretta, Maria Piera ^a   Chiariello, Massimo ^a   Cuocolo, Alberto ^a,d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b MOUNT SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d IRCCS SDN   (Italy)

Author keywords

Atherosclerosis; FDG PET; Molecular imaging; MRI; Ultrasound imaging

Indexed keywords

ALPHA2BBETA3 INTEGRIN; ANTIINFLAMMATORY AGENT; CATHEPSIN; CELL ADHESION MOLECULE; FIBRIN; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; INTEGRIN; LIPID; LIPOCORTIN 5 TC 99M; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR I 123; MATRIX METALLOPROTEINASE INHIBITOR I 125; MATRIX METALLOPROTEINASE INHIBITOR TC 99M; MONOCLONAL ANTIBODY; MONOCYTE CHEMOATTRACTANT PROTEIN 1 TC 99M; NANOPARTICLE; RADIOISOTOPE; THROMBOPLASTIN; TRACER; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANGIOGENESIS; AORTA ATHEROSCLEROSIS; APOPTOSIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BREATHING MECHANICS; CARDIOVASCULAR RISK; CAROTID ARTERY DISEASE; CELL ACTIVATION; CONTRAST ENHANCEMENT; CORONARY ARTERY ATHEROSCLEROSIS; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FLUORINE NUCLEAR MAGNETIC RESONANCE; HUMAN; MACROPHAGE; MICROBUBBLE; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROTEIN DEGRADATION; REPRODUCIBILITY; REVIEW; THROMBOGENICITY; THROMBOSIS; TRANSLATIONAL RESEARCH; TREATMENT RESPONSE; VASCULITIS; VASODILATATION;

ANIMALS; ATHEROSCLEROSIS; HUMANS; MAGNETIC RESONANCE IMAGING; MOLECULAR IMAGING; TRANSLATIONAL RESEARCH;

EID: 79953679851     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1697-5     Document Type: Review

References (39)

1. Gaziano JM. Global burden of cardiovascular disease, in Braunwald's heart disease: a textbook of cardiovascular medicine. 8th ed. Elsevier Saunders: Philadelphia; 2008.
2. D Lloyd-Jones R Adams M Carnethon G De Simone TB Ferguson K Flegal, et al. 2009 Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 119 480 486 19171871 10.1161/CIRCULATIONAHA.108.191259
3. JA Ambrose V Fuster 1998 The risk of coronary occlusion is not proportional to the prior severity of coronary stenoses Heart 79 3 4 9505906 1:STN:280:DyaK1c7ms1yjtw%3D%3D (Pubitemid 28179050)
4. J Sanz ZA Fayad 2008 Imaging of atherosclerotic cardiovascular disease Nature 451 953 957 18288186 10.1038/nature06803 1:CAS:528:DC%2BD1cXit1yntrw%3D (Pubitemid 351305938)
5. HF Langer R Haubner BJ Pichler M Gawaz 2008 Radionuclide imaging: a molecular key to the atherosclerotic plaque J Am Coll Cardiol 52 1 12 18582628 10.1016/j.jacc.2008.03.036 1:CAS:528:DC%2BD1cXnvVGlt7o%3D (Pubitemid 351852936)
6. D Hartung A Petrov N Haider S Fujimoto F Blankenberg A Fujimoto, et al. 2007 Radiolabeled monocyte chemotactic protein 1 for the detection of inflammation in experimental atherosclerosis J Nucl Med 48 1816 1821 17942805 10.2967/jnumed.107.043463 (Pubitemid 350099327)
7. S Ishino T Mukai Y Kuge N Kume M Ogawa N Takai, et al. 2008 Targeting of lectinlike oxidized low-density lipoprotein receptor 1 (LOX-1) with 99mTc-labeled anti-LOX-1 antibody: potential agent for imaging of vulnerable plaque J Nucl Med 49 1677 1685 18794262 10.2967/jnumed.107.049536 1:CAS:528:DC%2BD1cXhtlSgtrfJ
8. S Fujimoto D Hartung S Ohshima DS Edwards J Zhou P Yalamanchili, et al. 2008 Molecular imaging of matrix metalloproteinase in atherosclerotic lesions: resolution with dietary modification and statin therapy J Am Coll Cardiol 52 1847 1857 19038682 10.1016/j.jacc.2008.08.048 1:CAS:528:DC%2BD1cXhsVeqsrzE
9. S Isobe S Tsimikas J Zhou S Fujimoto M Sarai MJ Branks, et al. 2006 Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5 J Nucl Med 47 1497 1505 16954559 1:CAS:528:DC%2BD28XhtVCmtLfM (Pubitemid 47544938)
10. M Gawaz I Konrad AI Hauser S Sauer Z Li HJ Wester, et al. 2005 Non-invasive imaging of glycoprotein VI binding to injured arterial lesions Thromb Haemost 93 910 913 15886808 1:CAS:528:DC%2BD2MXktlaitLg%3D (Pubitemid 40691549)
11. JR Davies JH Rudd PL Weissberg J Narula 2006 Radionuclide imaging for the detection of inflammation in vulnerable plaques J Am Coll Cardiol 47 C57 C68 16631511 10.1016/j.jacc.2005.11.049 1:CAS:528:DC%2BD28XksVKmtrY%3D
12. A Tawakol RQ Migrino GG Bashian S Bedri D Vermylen RC Cury, et al. 2006 In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients J Am Coll Cardiol 48 1818 1824 17084256 10.1016/j.jacc.2006.05.076 (Pubitemid 44648622)
13. JH Rudd EA Warburton TD Fryer HA Jones JC Clark N Antoun, et al. 2002 Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography Circulation 105 2708 2711 12057982 10.1161/01.CIR.0000020548.60110.76 1:STN:280:DC%2BD38zhsFCisg%3D%3D (Pubitemid 34615139)
14. N Tahara H Kai H Nakaura M Mizoguchi M Ishibashi H Kaida, et al. 2007 The prevalence of inflammation in carotid atherosclerosis: analysis with fluorodeoxyglucose-positron emission tomography Eur Heart J 28 2243 2248 17681956 10.1093/eurheartj/ehm245 1:CAS:528:DC%2BD2sXht1amsLnI (Pubitemid 47428937)
15. JR Davies JH Rudd TD Fryer MJ Graves JC Clark PJ Kirkpatrick, et al. 2005 Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging Stroke 36 2642 2647 16282536 10.1161/01.STR.0000190896.67743. b1
16. JH Rudd KS Myers S Bansilal J Machac M Woodward V Fuster, et al. 2009 Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study Circ Cardiovasc Imaging 2 107 115 19808576 10.1161/CIRCIMAGING.108.811752
17. N Tahara H Kai S Yamagishi M Mizoguchi H Nakaura M Ishibashi, et al. 2007 Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome J Am Coll Cardiol 49 1533 1539 17418291 10.1016/j.jacc.2006.11.046 1:CAS:528:DC%2BD2sXjvFGgtL8%3D (Pubitemid 46517964)
18. B Paulmier M Duet R Khayat N Pierquet-Ghazzar JP Laissy C Maunoury, et al. 2008 Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events J Nucl Cardiol 15 209 217 18371592 10.1016/j.nuclcard.2007.10.009 (Pubitemid 351396317)
19. A Rominger T Saam S Wolpers CC Cyran M Schmidt S Foerster, et al. 2009 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease J Nucl Med 50 1611 1620 19759117 10.2967/jnumed.109.065151
20. N Tahara H Kai M Ishibashi H Nakaura H Kaida K Baba, et al. 2006 Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography J Am Coll Cardiol 48 1825 1831 17084257 10.1016/j.jacc.2006.03.069 1:CAS:528:DC%2BD28XhtFOjtb%2FE (Pubitemid 44648621)
21. JH Rudd KS Myers S Bansilal J Machac CA Pinto C Tong, et al. 2008 Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations J Nucl Med 49 871 878 18483100 10.2967/jnumed.107.050294 (Pubitemid 351793426)
22. T Saam A Rominger S Wolpers K Nikolaou C Rist M Greif, et al. 2010 Association of inflammation of the left anterior descending coronary artery with cardiovascular risk factors, plaque burden and pericardial fat volume: a PET/CT study Eur J Nucl Med Mol Imaging 37 1203 1212 20300933 10.1007/s00259-010-1432- 2
23. J Wykrzykowska S Lehman G Williams JA Parker MR Palmer S Varkey, et al. 2009 Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation J Nucl Med 50 563 568 19289431 10.2967/jnumed.108.055616
24. M Teräs T Kokki N Durand-Schaefer T Noponen M Pietilä J Kiss, et al. 2010 Dual-gated cardiac PET-clinical feasibility study Eur J Nucl Med Mol Imaging 37 505 516 19789872 10.1007/s00259-009-1252-4
25. IS Rogers K Nasir AL Figueroa RC Cury U Hoffmann DA Vermylen, et al. 2010 Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina JACC Cardiovasc Imaging 3 388 397 20394901 10.1016/j.jcmg.2010.01.004
26. K Kato A Nishio N Kato H Usami T Fujimaki T Murohara 2010 Uptake of 18F-FDG in acute aortic dissection: a determinant of unfavorable outcome J Nucl Med 51 674 681 20395325 10.2967/jnumed.109.065227
27. RL Wilensky HK Song VA Ferrari 2006 Role of magnetic resonance and intravascular magnetic resonance in the detection of vulnerable plaques J Am Coll Cardiol 47 C48 C56 16631510 10.1016/j.jacc.2005.11.048
28. I Kawahara M Morikawa M Honda N Kitagawa K Tsutsumi I Nagata, et al. 2007 High-resolution magnetic resonance imaging using gadolinium-based contrast agent for atherosclerotic carotid plaque Surg Neurol 68 60 65 17586225 10.1016/j.surneu.2006.09.037 (Pubitemid 46935289)
29. PM Winter AM Neubauer SD Caruthers TD Harris JD Robertson TA Williams, et al. 2006 Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis Arterioscler Thromb Vasc Biol 26 2103 2109 16825592 10.1161/01.ATV.0000235724.11299.76 1:CAS:528:DC%2BD28XotVWlt78%3D (Pubitemid 44253795)
30. PM Winter SD Caruthers H Zhang TA Williams SA Wickline GM Lanza 2008 Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis JACC Cardiovasc Imaging 1 624 634 19356492 10.1016/j.jcmg.2008.06.003
31. F Hyafil JP Laissy M Mazighi D Tchétché L Louedec H Adle-Biassette, et al. 2006 Ferumoxtran-10-enhanced MRI of the hypercholesterolemic rabbit aorta: relationship between signal loss and macrophage infiltration Arterioscler Thromb Vasc Biol 26 176 181 16269663 10.1161/01.ATV.0000194098.82677.57 1:CAS:528:DC%2BD2MXhtlagt7jO (Pubitemid 43732246)
32. RA Trivedi JM U-King-Im MJ Graves JJ Cross J Horsley MJ Goddard, et al. 2004 In vivo detection of macrophages in human carotid atheroma: temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI Stroke 35 1631 1635 15166394 10.1161/01.STR.0000131268.50418.b7 (Pubitemid 38823638)
33. SP Howarth TY Tang R Trivedi R Weerakkody J U-King-Im ME Gaunt, et al. 2009 Utility of USPIO-enhanced MR imaging to identify inflammation and the fibrous cap: a comparison of symptomatic and asymptomatic individuals Eur J Radiol 70 555 560 18356000 10.1016/j.ejrad.2008.01.047 1:STN:280: DC%2BD1MvhsV2lsg%3D%3D
34. DE Sosnovik 2008 Molecular imaging in cardiovascular magnetic resonance imaging: current perspective and future potential Top Magn Reson Imaging 19 59 68 18690161 10.1097/RMR.0b013e318176c57b
35. FS Villanueva WR Wagner 2008 Ultrasound molecular imaging of cardiovascular disease Nat Clin Pract Cardiovasc Med 5 S26 S32 18641604 10.1038/ncpcardio1246 1:CAS:528:DC%2BD1cXoslensbc%3D
36. S Coli M Magnoni G Sangiorgi MM Marrocco-Trischitta G Melisurgo A Mauriello, et al. 2008 Contrast-enhanced ultrasound imaging of intraplaque neovascularization in carotid arteries: correlation with histology and plaque echogenicity J Am Coll Cardiol 52 223 230 18617072 10.1016/j.jacc.2008.02.082 (Pubitemid 351915779)
37. PL Weissberg 2004 Noninvasive imaging of atherosclerosis: the biology behind the pictures J Nucl Med 45 1794 1795 15534045 (Pubitemid 47618433)
38. S Ben-Haim E Kupzov A Tamir A Frenkel O Israel 2006 Changing patterns of abnormal vascular wall F-18 fluorodeoxyglucose uptake on follow-up PET/CT studies J Nucl Cardiol 13 791 800 17174810 10.1016/j.nuclcard.2006.07.008 (Pubitemid 44890808)
39. LJ Menezes I Kayani S Ben-Haim B Hutton PJ Ell AM Groves 2010 What is the natural history of 18F-FDG uptake in arterial atheroma on PET/CT? Implications for imaging the vulnerable plaque Atherosclerosis 211 136 140 20202634 10.1016/j.atherosclerosis.2010.01.012 1:CAS:528:DC%2BC3cXos1yit7k%3D